β-aminopropionitrile-induced thoracic aortopathy is refractory to cilostazol and sildenafil in mice. [PDF]
Thoracic aortopathies are life-threatening diseases including aneurysm, dissection, and rupture. Cilostazol, a phosphodiesterase (PDE) 3 inhibitor, and sildenafil, a PDE5 inhibitor, have been used clinically for peripheral arterial disease and erectile ...
Samuel C Tyagi +7 more
doaj +2 more sources
Exploring ethnic differences in the perioperative course of thoracic aortopathy [PDF]
BackgroundIn patients with thoracic aortopathy post-operative recovery can be complicated by a lack of consistent, clear communication and guidance. Despite the growing recognition of these challenges, the specific needs of patients undergoing aortic ...
Nora Bacour +7 more
doaj +2 more sources
Aortopathy in Tetralogy of Fallot – Insights from a single-center observational study [PDF]
Objective: The objective of this study was to assess the presence of aortopathy on follow-up in operated and unoperated adolescent and adult patients with Tetralogy of Fallot (TOF) and to identify the various associated factors.
Usnish Adhikari +3 more
doaj +2 more sources
Emerging imaging and circulating biomarkers in relation to underlying mechanisms in Bicuspid Aortic Valve aortopathy [PDF]
Bicuspid Aortic Valve (BAV) is the most prevalent congenital heart defect with an autosomal dominant inheritance. With up to 2% of the general population affected by the condition, mortality remains high likely due to the development of aortopathy which ...
Hamza M Ahmad +4 more
doaj +2 more sources
Connective tissue disorder and high risk pregnancy: a case series with personalised external aortic root support (PEARS) [PDF]
Aortopathy including Marfan (MFS) and Loeys-Dietz syndrome (LDS) poses a high risk of aortic dissection, particularly during pregnancy and the puerperium.
Claudia Montanaro +12 more
doaj +2 more sources
Aortopathy associated with bicuspid aortic valve: advances in clinical and hemodynamics research [PDF]
Having a bicuspid aortic valve (BAV) is the most common congenital heart disease, affecting 0.5%–2% of the population, with significant heterogeneity in clinical presentation, complications, and outcomes.
Minghui Yang +4 more
doaj +2 more sources
Background: Using echocardiographic surveillance, many patients are diagnosed with bicuspid aortic valve (BAV) without significant valve dysfunction. Limited data are available regarding the progression and outcomes of non-dysfunctional BAV.Methods and ...
Shinjeong Song +5 more
doaj +1 more source
Long-term outcomes in heritable thoracic aortic disease
Heritable aortic aneurysm is an increasingly recognized cause of morbidity and mortality. Whilst Marfan syndrome (MFS) is well-known, the clinical presentation and prognosis of more newly described genetic syndromes is less familiar to clinicians.
Elizabeth N. Robertson +7 more
doaj +1 more source
Clinical implications of the biomechanics of bicuspid aortic valve and bicuspid aortopathy
Bicuspid aortic valve (BAV), which affects up to 2% of the general population, results from the abnormal fusion of the cusps of the aortic valve. Patients with BAV are at a higher risk for developing aortic dilatation, a condition known as bicuspid ...
Ali Fatehi Hassanabad +9 more
doaj +1 more source
Background Primary and secondary aortopathy are frequently encountered in patients with congenital heart disease. The aim of this study is to present our experience and the incidence of primary and secondary adult CHD-associated aortopathy.
Ingrid Schusterova +4 more
doaj +1 more source

